
MorphoSys AG MOR
Annual report 2023
added 12-27-2025
MorphoSys AG Historical Prices 2011-2026 | MOR
Annual Historical Prices MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.2 | 7.61 | 9.42 | 28.3 | 35.7 | 25.3 | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.7 | 7.61 | 20.8 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Adagene
ADAG
|
1.56 | $ 2.19 | 7.88 % | $ 123 M | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
BioLineRx Ltd.
BLRX
|
2.65 | $ 3.03 | 2.35 % | $ 908 M | ||
|
BioNTech SE
BNTX
|
95.4 | $ 117.93 | -0.46 % | $ 27.2 B | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.31 | 1.22 % | $ 7.96 B | ||
|
BioXcel Therapeutics
BTAI
|
2.12 | $ 1.83 | 0.83 % | $ 4.64 M | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 9.64 | -2.33 % | $ 1.58 B | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 4.23 | 1.68 % | $ 9.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
27 | $ 26.09 | -0.21 % | $ 1.26 B | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
Coherus BioSciences
CHRS
|
2.22 | $ 2.03 | 27.67 % | $ 191 M | ||
|
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | ||
|
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | ||
|
Ascendis Pharma A/S
ASND
|
153 | $ 230.76 | 0.92 % | $ 5 B | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
Aytu BioScience
AYTU
|
2.51 | $ 2.72 | 0.37 % | $ 17.1 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
63.4 | $ 42.02 | 1.74 % | $ 4.34 B | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
20.6 | $ 24.23 | -0.9 % | $ 2.87 B | ||
|
Arrowhead Pharmaceuticals
ARWR
|
46.7 | $ 70.82 | 1.77 % | $ 9.47 B | ||
|
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Champions Oncology
CSBR
|
7.75 | $ 6.9 | -0.43 % | $ 94.3 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | ||
|
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
Biogen
BIIB
|
133 | $ 171.66 | -1.23 % | $ 25 B | ||
|
Bio-Path Holdings
BPTH
|
6.15 | - | - | $ 100 K | ||
|
BioVie
BIVI
|
1.65 | $ 1.26 | 0.79 % | $ 1.86 M | ||
|
Baudax Bio
BXRX
|
2.35 | - | 0.59 % | $ 63 K |